3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
2
Withdrawn
1
Terminated
1
Recruiting
1
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Neoplasms
1
Febrile Neutropenia
1
Interventions
pegylated granulocyte colony-stimulating factor
1
Meropenem
1
Ciprofloxacin
1
Ceftazidime
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Febrile Neutropenia
×
Meropenem
×
Clear all
NCT06293677
2024-07-11
DAR-ARC
Centre Hospitalier Universitaire Vaudois
Phase 4
Recruiting
30 enrolled